BANK OF MONTREAL /CAN/ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2017$4,0000.0%1,0000.0%0.00%
Q4 2016$4,000
-20.0%
1,0000.0%0.00%
Q3 2016$5,000
+25.0%
1,0000.0%0.00%
Q2 2016$4,0000.0%1,0000.0%0.00%
Q1 2016$4,0001,0000.0%0.00%
Q4 2015$01,0000.0%0.00%
Q3 2015$0
-100.0%
1,0000.0%0.00%
Q2 2015$7,000
+16.7%
1,0000.0%0.00%
Q1 2015$6,000
+50.0%
1,0000.0%0.00%
Q4 2014$4,0000.0%1,0000.0%0.00%
Q3 2014$4,0001,0000.0%0.00%
Q2 2014$01,0000.0%0.00%
Q1 2014$01,0000.0%0.00%
Q4 2013$0
-100.0%
1,0000.0%0.00%
Q3 2013$4,000
+33.3%
1,0000.0%0.00%
Q2 2013$3,0001,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2016
NameSharesValueWeighting ↓
Amici Capital, LLC 8,000,000$53,880,0001.96%
Baker Brothers Advisors 22,379,000$149,970,0001.32%
GEODE CAPITAL MANAGEMENT, LLC 1,000,000$6,732,0000.00%
UBS Group AG 22,000$148,0000.00%
BANK OF AMERICA CORP /DE/ 2,000$13,0000.00%
MORGAN STANLEY 14,000$94,0000.00%
BANK OF MONTREAL /CAN/ 1,000$7,0000.00%
ROYAL BANK OF CANADA 2,000$12,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders